IMVT
Price
$16.24
Change
-$0.15 (-0.92%)
Updated
Jun 30, 10:47 AM (EDT)
Capitalization
2.75B
37 days until earnings call
SLNO
Price
$83.25
Change
-$0.77 (-0.92%)
Updated
Jun 27 closing price
Capitalization
4.2B
37 days until earnings call
Interact to see
Advertisement

IMVT vs SLNO

Header iconIMVT vs SLNO Comparison
Open Charts IMVT vs SLNOBanner chart's image
Immunovant
Price$16.24
Change-$0.15 (-0.92%)
Volume$300
Capitalization2.75B
Soleno Therapeutics
Price$83.25
Change-$0.77 (-0.92%)
Volume$3.28M
Capitalization4.2B
IMVT vs SLNO Comparison Chart in %
Loading...
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMVT vs. SLNO commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMVT is a Buy and SLNO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (IMVT: $16.10 vs. SLNO: $83.25)
Brand notoriety: IMVT and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMVT: 217% vs. SLNO: 371%
Market capitalization -- IMVT: $2.75B vs. SLNO: $4.2B
IMVT [@Biotechnology] is valued at $2.75B. SLNO’s [@Biotechnology] market capitalization is $4.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMVT’s FA Score shows that 0 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • IMVT’s FA Score: 0 green, 5 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, both IMVT and SLNO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMVT’s TA Score shows that 6 TA indicator(s) are bullish while SLNO’s TA Score has 4 bullish TA indicator(s).

  • IMVT’s TA Score: 6 bullish, 3 bearish.
  • SLNO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IMVT is a better buy in the short-term than SLNO.

Price Growth

IMVT (@Biotechnology) experienced а +1.90% price change this week, while SLNO (@Biotechnology) price change was +4.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.65%. For the same industry, the average monthly price growth was +32.92%, and the average quarterly price growth was +6.78%.

Reported Earning Dates

IMVT is expected to report earnings on Aug 06, 2025.

SLNO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($4.2B) has a higher market cap than IMVT($2.75B). SLNO YTD gains are higher at: 85.206 vs. IMVT (-35.002). SLNO has higher annual earnings (EBITDA): -194.63M vs. IMVT (-437.78M). IMVT has more cash in the bank: 714M vs. SLNO (290M). IMVT has less debt than SLNO: IMVT (98K) vs SLNO (52.8M). IMVT (0) and SLNO (0) have equivalent revenues.
IMVTSLNOIMVT / SLNO
Capitalization2.75B4.2B66%
EBITDA-437.78M-194.63M225%
Gain YTD-35.00285.206-41%
P/E RatioN/AN/A-
Revenue00-
Total Cash714M290M246%
Total Debt98K52.8M0%
FUNDAMENTALS RATINGS
IMVT vs SLNO: Fundamental Ratings
IMVT
SLNO
OUTLOOK RATING
1..100
5850
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
10060
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
6237
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
27n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMVT's Valuation (43) in the null industry is somewhat better than the same rating for SLNO (100) in the Medical Specialties industry. This means that IMVT’s stock grew somewhat faster than SLNO’s over the last 12 months.

SLNO's Profit vs Risk Rating (60) in the Medical Specialties industry is somewhat better than the same rating for IMVT (100) in the null industry. This means that SLNO’s stock grew somewhat faster than IMVT’s over the last 12 months.

IMVT's SMR Rating (97) in the null industry is in the same range as SLNO (98) in the Medical Specialties industry. This means that IMVT’s stock grew similarly to SLNO’s over the last 12 months.

SLNO's Price Growth Rating (37) in the Medical Specialties industry is in the same range as IMVT (62) in the null industry. This means that SLNO’s stock grew similarly to IMVT’s over the last 12 months.

SLNO's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as IMVT (100) in the null industry. This means that SLNO’s stock grew similarly to IMVT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMVTSLNO
RSI
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
89%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 14 days ago
84%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IMVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SEITX13.560.12
+0.89%
SEI International Equity F (SIT)
LOMAX15.470.09
+0.59%
Edgar Lomax Value
LYRCX28.090.09
+0.32%
Lyrical US Value Equity C
RSEBX69.470.21
+0.30%
American Funds SMALLCAP World R2E
PMVAX20.140.04
+0.20%
Putnam Sustainable Future A

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
-1.77%
ROIV - IMVT
62%
Loosely correlated
-1.81%
OCUL - IMVT
55%
Loosely correlated
-2.54%
CGON - IMVT
54%
Loosely correlated
-0.46%
IDYA - IMVT
52%
Loosely correlated
-4.13%
DNLI - IMVT
52%
Loosely correlated
-2.69%
More

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with SYRE. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
-0.92%
SYRE - SLNO
43%
Loosely correlated
-4.99%
NKTX - SLNO
43%
Loosely correlated
-3.18%
IMVT - SLNO
39%
Loosely correlated
-1.77%
CRNX - SLNO
39%
Loosely correlated
-0.10%
IDYA - SLNO
39%
Loosely correlated
-4.13%
More